{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:45:53Z","timestamp":1778154353696,"version":"3.51.4"},"reference-count":26,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["16\/0005407"],"award-info":[{"award-number":["16\/0005407"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["098395\/Z\/12\/Z"],"award-info":[{"award-number":["098395\/Z\/12\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["110082\/Z\/15\/Z"],"award-info":[{"award-number":["110082\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Royal Society \/ Wellcome Trust","award":["105636\/Z\/14\/Z"],"award-info":[{"award-number":["105636\/Z\/14\/Z"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2019,11,11]]},"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Insulin secretion in sulfonylurea-treated <jats:italic>KCNJ11<\/jats:italic> permanent neonatal diabetes mellitus (PNDM) is thought to be mediated predominantly through amplifying non-K<jats:sub>ATP<\/jats:sub>-channel pathways such as incretins. Affected individuals report symptoms of postprandial hypoglycemia after eating protein\/fat-rich foods. We aimed to assess the physiological response to carbohydrate and protein\/fat in people with sulfonylurea-treated <jats:italic>KCNJ11<\/jats:italic> PNDM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>5 adults with sulfonylurea-treated <jats:italic>KCNJ11<\/jats:italic> PNDM and five age, sex and body mass index-matched controls without diabetes had a high-carbohydrate and high-protein\/fat meal on two separate mornings. Insulin(i) and glucose(g) were measured at baseline then regularly over 4\u2009hours after the meal. Total area under the curve (tAUC) for insulin and glucose was calculated over 4\u2009hours and compared between meals in controls and <jats:italic>KCNJ11<\/jats:italic> cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In controls, glucose values after carbohydrate and protein\/fat were similar (median glucose tAUC<jats:sub>0-4h<\/jats:sub>21.4 vs 19.7\u2009mmol\/L, p=0.08). In <jats:italic>KCNJ11<\/jats:italic> cases glucose levels were higher after carbohydrate than after protein\/fat (median glucose tAUC<jats:sub>0-4h<\/jats:sub>58.1 vs 31.3\u2009mmol\/L, p=0.04). These different glycemic responses reflected different patterns of insulin secretion: in controls, insulin secretion was greatly increased after carbohydrate versus protein\/fat (median insulin tAUC<jats:sub>0-4h<\/jats:sub>727 vs 335\u2009pmol\/L, p=0.04), but in <jats:italic>KCNJ11<\/jats:italic> cases insulin secretion was similar after carbohydrate and protein\/fat (median insulin tAUC<jats:sub>0-4h<\/jats:sub>327 vs 378\u2009pmol\/L, p=0.50).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Individuals with sulfonylurea-treated <jats:italic>KCNJ11<\/jats:italic> PNDM produce similar levels of insulin in response to both carbohydrate and protein\/fat meals despite carbohydrate resulting in much higher glucose levels and protein\/fat resulting in relatively low glucose levels. This suggests in an inability to modulate insulin secretion in response to glucose levels, consistent with a dependence on non-K<jats:sub>ATP<\/jats:sub> pathways for insulin secretion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"NCT02921906\">NCT02921906<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2019-000721","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T06:15:16Z","timestamp":1576736116000},"page":"e000721","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated <i>KCNJ11<\/i> neonatal diabetes show predominance of non-K<sub>ATP<\/sub>-channel pathways"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-7700","authenticated-orcid":false,"given":"Pamela","family":"Bowman","sequence":"first","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J","family":"McDonald","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget A","family":"Knight","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Leveridge","sequence":"additional","affiliation":[{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve R","family":"Spaull","sequence":"additional","affiliation":[{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3785-327X","authenticated-orcid":false,"given":"Beverley M","family":"Shields","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Hammersley","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie H","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C","family":"Andrews","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-8104","authenticated-orcid":false,"given":"Kashyap A","family":"Patel","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T","family":"Hattersley","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, Devon, UK"},{"name":"Exeter NIHR Clinical Research Facility, Exeter, Devon, UK"},{"name":"Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"key":"2025073111511799000_7.1.e000721.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60098-8"},{"key":"2025073111511799000_7.1.e000721.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055068"},{"key":"2025073111511799000_7.1.e000721.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032922"},{"key":"2025073111511799000_7.1.e000721.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061759"},{"key":"2025073111511799000_7.1.e000721.5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-8587(18)30106-2","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","volume":"6","author":"Bowman","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111511799000_7.1.e000721.6","doi-asserted-by":"crossref","unstructured":"Lanning MS , Carmody D , Szczerbinski L , et al . Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures. Pediatr Diabetes 2017.","DOI":"10.1111\/pedi.12599"},{"key":"2025073111511799000_7.1.e000721.7","unstructured":"Diabetes Genes . Sulphonylurea transfer in patients with KCNJ11 and ABCC8 mutations \u2013 PNDM. Available: https:\/\/www.diabetesgenes.org\/about-neonatal-diabetes\/su-transfer-in-patients-with-kcnj11-and-abcc8-mutations-pndm\/ [Accessed 2 Mar 2019]."},{"key":"2025073111511799000_7.1.e000721.8","doi-asserted-by":"crossref","unstructured":"Cen J , Sargsyan E , Bergsten P . Fatty acids stimulate insulin secretion from human pancreatic islets at fasting glucose concentrations via mitochondria-dependent and -independent mechanisms. Nutr Metab 2016;13.doi:10.1186\/s12986-016-0119-5","DOI":"10.1186\/s12986-016-0119-5"},{"key":"2025073111511799000_7.1.e000721.9","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/db06-S003","article-title":"Fatty acid signaling in the beta-cell and insulin secretion","volume":"55 Suppl 2","author":"Nolan","year":"2006","journal-title":"Diabetes"},{"key":"2025073111511799000_7.1.e000721.10","first-page":"617","article-title":"Effect of amino acids and proteins on insulin secretion in man","volume":"23","author":"Fajans","year":"1967","journal-title":"Recent Prog Horm Res"},{"key":"2025073111511799000_7.1.e000721.11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/abbs\/gms107","article-title":"Mechanisms of amino acid-stimulated insulin secretion in congenital hyperinsulinism","volume":"45","author":"Zhang","year":"2013","journal-title":"Acta Biochim Biophys Sin"},{"key":"2025073111511799000_7.1.e000721.12","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/diabetes.53.suppl_3.S181","article-title":"Atp-Sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-\/- mouse alpha-cells","volume":"53 Suppl 3","author":"Gromada","year":"2004","journal-title":"Diabetes"},{"key":"2025073111511799000_7.1.e000721.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00956-1"},{"key":"2025073111511799000_7.1.e000721.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050143","article-title":"A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans","volume":"5","author":"MacDonald","year":"2007","journal-title":"PLoS Biol"},{"key":"2025073111511799000_7.1.e000721.15","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0193"},{"key":"2025073111511799000_7.1.e000721.16","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1808"},{"key":"2025073111511799000_7.1.e000721.17","doi-asserted-by":"publisher","DOI":"10.2337\/diab.27.4.370"},{"key":"2025073111511799000_7.1.e000721.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.09.002"},{"key":"2025073111511799000_7.1.e000721.19","first-page":"205","article-title":"Gastric emptying of liquids and solids evaluated by acetaminophen test in diabetic patients with and without autonomic neuropathy","volume":"13","author":"Cavallo-Perin","year":"1991","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"2025073111511799000_7.1.e000721.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.02.033"},{"key":"2025073111511799000_7.1.e000721.21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311502200"},{"key":"2025073111511799000_7.1.e000721.22","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1195"},{"key":"2025073111511799000_7.1.e000721.23","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0347"},{"key":"2025073111511799000_7.1.e000721.24","doi-asserted-by":"publisher","DOI":"10.1038\/87455"},{"key":"2025073111511799000_7.1.e000721.25","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.10.2542"},{"key":"2025073111511799000_7.1.e000721.26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmet.2018.08.001","article-title":"Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes","volume":"17","author":"Chakera","year":"2018","journal-title":"Mol Metab"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2019-000721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:51:24Z","timestamp":1753987884000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2019-000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,18]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1136\/bmjdrc-2019-000721"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2019-000721","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}